Sign in to view content

How Do I Decide to Treat Patients with Geographic Atrophy?

Glenn J. Jaffe, MD

Video
Published 2024

Related

Evaluation of 8 mg Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration: Results from the Phase 2 CANDELA Study
W. Lloyd Clark, MD, FASRS
Updates from the Field
2022
Therapeutic Horizons for Dry AMD
Robert L. Avery, MD
Updates from the Field
2019
Results from Part 1 of the Phase 2/3 SIGLEC Trial Assessing AVD-104 for Geographic Atrophy: Glyco-immunologic Modulation of Macrophage Activity
Rishi P. Singh, MD
Updates from the Field
2024

Category: Geographic Atrophy

See more